MRE-269
| SMILES | OC(=O)COCCCCN(c1cnc(c(n1)c1ccccc1)c1ccccc1)C(C)C |
| InChIKey | OJQMKCBWYCWFPU-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 5 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 11 |
| Molecular weight (Da) | 419.2 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Database connections
| Structure pdb | 8X79 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| EP2 | PE2R2 | Human | Prostanoid | A | pKi | 5.24 | 5.24 | 5.24 | Guide to Pharmacology |
| EP4 | PE2R4 | Human | Prostanoid | A | pKi | 5.31 | 5.31 | 5.31 | Guide to Pharmacology |
| IP | PI2R | Human | Prostanoid | A | pKi | 7.7 | 7.7 | 7.7 | Guide to Pharmacology |
| IP | PI2R | Rat | Prostanoid | A | pKi | 6.66 | 6.66 | 6.66 | Guide to Pharmacology |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| DP1 | PD2R | Human | Prostanoid | A | pEC50 | 6.81 | 6.81 | 6.81 | ChEMBL |
| IP | PI2R | Human | Prostanoid | A | pIC50 | 6.54 | 6.54 | 6.54 | ChEMBL |
| IP | PI2R | Human | Prostanoid | A | pEC50 | 7.66 | 7.66 | 7.66 | ChEMBL |